Supplementary Figure Legend from Combining Oncolytic HSV-1 with Immunogenic Cell Death-Inducing Drug Mitoxantrone Breaks Cancer Immune Tolerance and Improves Therapeutic Efficacy
Authors:
- Samuel T. WorkenheSWSamuel T. Workenhe
- Jonathan G. PolJPJonathan G. Pol
- Brian D. LichtyBLBrian D. Lichty
- Derek T. CummingsDCDerek T. Cummings
- Karen L. MossmanKMKaren L. Mossman
Open Access
- 3 April 2023
- other
- Published by American Association for Cancer Research (AACR)